Annexon, Inc. Profile Avatar - Palmy Investing

Annexon, Inc.

Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets disti…

Biotechnology
US, Brisbane [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Annexon, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Annexon, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Annexon, Inc..

End of ANNX's Analysis
CIK: 1528115 CUSIP: 03589W102 ISIN: US03589W1027 LEI: - UEI: -
Secondary Listings
ANNX has no secondary listings inside our databases.